Richard Scott Struthers - Jul 11, 2023 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
President & CEO, Director
Signature
/s/ Marc Wilson, as attorney-in-fact
Stock symbol
CRNX
Transactions as of
Jul 11, 2023
Transactions value $
-$1,010,317
Form type
4
Date filed
7/13/2023, 04:56 PM
Previous filing
Jun 21, 2023
Next filing
Aug 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Sale -$491K -24.4K -3.58% $20.14 656K Jul 11, 2023 By Family Trust 1 F1
transaction CRNX Common Stock Sale -$231K -11.5K -1.75% $20.17 645K Jul 12, 2023 By Family Trust 1 F2
transaction CRNX Common Stock Sale -$288K -14.2K -2.2% $20.35 631K Jul 13, 2023 By Family Trust 1 F3
holding CRNX Common Stock 126K Jul 11, 2023 Direct
holding CRNX Common Stock 1K Jul 11, 2023 By Spouse
holding CRNX Common Stock 90K Jul 11, 2023 By Family Trust 2
holding CRNX Common Stock 90K Jul 11, 2023 By Family Trust 3
holding CRNX Common Stock 90K Jul 11, 2023 By Family Trust 4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $20.14 per share. The range of sales prices on the transaction date was $20.10 to $20.25 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request
F2 The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $20.17 per share. The range of sales prices on the transaction date was $20.10 to $20.31 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
F3 The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $20.35 per share. The range of sales prices on the transaction date was $20.10 to $20.68 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.